Susquehanna International Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $4.45M | Sell |
|
|||||
|
2024
Q1 | $4.8M | Sell |
|
|||||
|
2023
Q4 | $6.17M | Buy |
|
|||||
|
2023
Q3 | $583K | Sell |
|
|||||
|
2023
Q2 | $1.07M | Sell |
|
|||||
|
2023
Q1 | $2.42M | Buy |
|
|||||
|
2022
Q4 | $718K | Sell |
|
|||||
|
2022
Q3 | $1.63M | Buy |
|
|||||
|
2022
Q2 | $202K | Sell |
|
|||||
|
2022
Q1 | $1.19M | Sell |
|
|||||
|
2021
Q4 | $2.62M | Buy |
|
|||||
|
2021
Q3 | $1.32M | Buy |
|
|||||
|
2021
Q2 | $373K | Sell |
|
|||||
|
2021
Q1 | $2.58M | Buy |
|
|||||
|
2020
Q4 | $373K | Buy |
|